Moteur de recherche d’entreprises européennes

UK funding (27 554 £) : Identification et impact des polymères sur les produits de cellules souches dans une plateforme de biofabrication automatisée Ukri01/01/2024 UK Research and Innovation, Royaume Uni

Vue d’ensemble

Texte

Identification et impact des polymères sur les produits de cellules souches dans une plateforme de biofabrication automatisée

Abstract The culture of mammalian cells underpins almost all life science R&D, is involved in the production of many therapeutics including recombinant proteins, antibodies, vaccines and underpins many next-generation therapeutics such as cell therapies for personalised medicine. One significant bottleneck preventing the widespread adoption of such technologies and additionally, their incorporation into clinical practice, is the infrastructure needed to manufacture such therapies in technoeconomically feasible ways. Unicorn Biotechnologies has made an end-to-end automated modular and scalable cell manufacturing system that automatically manufactures such cell products with minimal user input. This project will enhance the quality and reproducibility of our manufacturing system further by working with state-of-the-art specialist governmental technology institutions to perform detailed chemical and biological characterization of the materials used in our biomanufacturing platform.
Category Collaborative R&D
Reference 10089013
Status Closed
Funded period start 01/01/2024
Funded period end 30/06/2024
Funded value £27 554,00
Source https://gtr.ukri.org/projects?ref=10089013

Participating Organisations

UNICORN BIOTECHNOLOGIES LTD

£27 554,00

NPL MANAGEMENT LIMITED
THE SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE ACTING THROUGH THE MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY (MHRA)

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Unicorn Biotechnologies Ltd., Sheffield, Royaume Uni.